[india-drug] Workshop-NIPER

[Viswanadh Bhoomi <bviswanad@yahoo.com>]

Workshop-NIPER
-----------------


Dear Friends, 
 
It gives me immense pleasure to inform you that, we (Dept. of
Pharmacology and Toxicology, NIPER, India) are organizing a workshop in
Pharmacology and Toxicology.  All the concerned can participate in the
same.   
 
The details workshop as follows:-
 
Workshop on DRUG DISCOVERY AND DEVELOPMENT IN NEW MILLENNIUMINTERFACING
WITH PHARMACOLOGICAL & TOXICOLOGICAL EXPERIMENTATION
February 26-29, 2004 at Department of Pharmacology and
ToxicologyNational Institute of Pharmaceutical Education and Research
(NIPER)(Ministry of Chemicals and Fertilizers)Sector-67, 
S.A.S. Nagar-160 062, Punjab, India
Phone: +91-172-(2214682-2214687) Fax: +91-172-2214692URL:
http://niper.nic.in 
 
THE WORKSHOP
 
Drug discovery and development is presently undergoing a paradigm
shift.  The new paradigm which is based on target identification &
validation, robust assay systems and chemical and biological
informatics has provided powerful momentum to drug discovery and
development.  Critical decision making
 related to therapeutic targets, lead generation and optimization and
biological screening strategies to clinical trials is the prime factor
for successful drug discovery.  Integration of such knowledge is the
order of the day to achieve enhanced productivity.  Pharmaceutical
companies which are striving to technologies and platforms.  It is
becoming clearer that considerable amount of money is lost on compounds
that fail late in the process because of their pharmacokinetic
properties and toxicity. Hence the toxicological screening should be
dropped in the beginning of discovery and developments. The four day
forum will provide students, researchers, managers and regulatory
authorities an insight in to the ways of in-depth understanding of the
different aspects of drug discovery and development.  Workshop will
have lectures as well as demonstrations.
 
TOPICS OF DELIBERATIONS
 
Lectures:      Changing trends in drug discovery     
Drug discovery research in India: opportunities & challenges:     
Newer platform technologies      Role of genomics in drug discovery    
 Molecular docking      Testing of potential compounds in in vitro
models such as insulin resistancev      Testing of potential compounds
in animal models such as stroke      G-Protein coupled receptors and
drug discoveryv      Safety Pharmacology      Treatment of ischemic
heart disease      Drug development for cataract      Oxidative stress
in neurological disorders      Receptor binding      Electrophysiology 
    Regulatory toxicology      Clinical trials
and GCP      Ethical issues Demonstrations:      Molecular Modeling    
 Receptor binding technique      Blood flow measurements using laser
doppler blood flow monitor      Stroke research setup      Molecular
biology techniques      Genotoxicity studies 
 
TENTATIVE LIST OF SPEAKERS
 
Dr. Abhijit Ray, Ranbaxy Dr. A. Sankaranarayanan, Torrent Research
Center Dr. C. Adithan, JIPMER Dr. C. L. Kaul, NIPER Dr. C.S. Dey, NIPER
Dr. K.B.
 Tikoo, NIPER Dr. Nilanjan Roy, NIPER Dr. P. Ramarao, NIPER Dr. P. V.
Bharatam, NIPER Dr. R. Rajagopalan, Dr. Reddys Dr. Rao V.S.V.
Vadlamudi, Suven Life Sciences Ltd.Dr. Sudarshan Arora, Lupin Dr. S.D.
Seth, ICMR Dr. S.K. Brahmachari, IGIB Dr. S.K. Gupta, AIIMS Dr. S.K.
Maulik, AIIMS Dr. S.S. Sharma, NIPER Dr. Sidhir Srivastava, CDRI Dr. V.
Muthuswamy, ICMR Dr. Y.K. Gupra, ITRC and few more????
 
 
WHO SHOULD ATTEND:
 
Pharmacologists and toxicologists working in R&D laboratoriesv     
Professionals in pharmaceutical companiesv      Govt. and University
Pharmacy professionalsv      Scientists in National laboratoriesv     
Personnel from regulatory authorities and quality control laboratoriesv
     Students from pharmacy profession. 
 
DURATION AND VENUE
 
The workshop will be from February 26-29, 2004. The course will be
conducted at NIPER, S.AS. Nagar (Mohali). 
 
ACCOMODATION
 
The participants shall be lodged in different guest houses and hostels
nearby.  Up to 20 participants will be accommodated in the
 institute?s guest house.  Accommodation shall be provided on first
come first basis and charges shall be in the range of Rs.100 (Hostel)
to Rs.200 (Guest House) per night.  Several good hostels are available
in the vicinity and can be arranged on additional payment. 
 
REGISTRATION
 
The request for registration should be submitted on the enclosed form. 
The registration fee is Rs. 1500/- for students, Rs. 3000/- for Govt.
academic & Scientists  and Rs. 6000/- for Industry participants. 
Paynment can be made in the from of demand draft in the name of
Director, NIPER and payable at Chandigarh or Mohali.  Please send
accommodation charges along with registration fee.  Note: Limited seats
are available on first come first bases.
 
For any other information, Please contact:
Dr. P. Rama Rao      Workshop Convener   
Dr. S.S. Sharma       Workshop Co-ordinator  
pramarao@niper.ac.in                                                   
        
sssharma@niper.ac.in
ramaraop@yahoo.com                                                     
        shyamsharm14@yahoo.com  
 
Department of Pharmacology and Toxicology
National Institute of Pharmaceutical Education and Research (NIPER)
(Ministry of Chemicals and Fertilizers)Sector-67, 
S.A.S. Nagar-160 062, Punjab, India
Phone: +91-172-(2214682-2214687) 
Fax: +91-172-2214692
URL: http://niper.nic.in 
 
 
Looking forward to hear more from you,With best regards
 
Viswanad Boomi
PhD Scholar
Cardiovascular and Receptorology Laboratory
Department of Pharmacology and Toxicology
National Institute of Pharmaceutical Education and Research (NIPER)
Sector-67, SAS Nagar, Punjab (INDIA) -160 062.
Ph:  +91-172-214682,214687, Fax: +91-172-214692.  


________________________________________________________________________
Yahoo! India Mobile: Download the latest polyphonic ringtones.
Go to http://in.mobile.yahoo.com

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org